Möbus, V., Jackisch, C., Lueck, H., Du Bois, A., Thomssen, C., Kuhn, W., . . . Morenz, B. (2018). Ten-year results of intense dose-dense chemotherapy show superior survival compared to a conventional schedule in high-risk primary breast Cancer: Final results of AGO phase III iddEPC trial. Annals of oncology, 29(1), . https://doi.org/10.1093/annonc/mdx690
Chicago Style (17th ed.) CitationMöbus, Volker, et al. "Ten-year Results of Intense Dose-dense Chemotherapy Show Superior Survival Compared to a Conventional Schedule in High-risk Primary Breast Cancer: Final Results of AGO Phase III IddEPC Trial." Annals of Oncology 29, no. 1 (2018). https://doi.org/10.1093/annonc/mdx690.
MLA (9th ed.) CitationMöbus, Volker, et al. "Ten-year Results of Intense Dose-dense Chemotherapy Show Superior Survival Compared to a Conventional Schedule in High-risk Primary Breast Cancer: Final Results of AGO Phase III IddEPC Trial." Annals of Oncology, vol. 29, no. 1, 2018, https://doi.org/10.1093/annonc/mdx690.